glp-1 in brain and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential The gut-brain axis for the

This emerging area of research has generated considerable interest among clinicians and patients alike

Biological activity of the endocannabinoid system Once in the body, 9 -THC and CBD exert their effects via the endocannabinoid system (ECS).The identification of the specific binding sites for 9 -THC in the brain [45], complemented by the cloning of the cannabinoid receptor 1 (CB1), that led to the development of the concept of a cannabinoid receptor system given the binding of 9 -THC to CB1 as a partial agonist [46]

The most common side effects include: Nausea Constipation or diarrhea Mild fatigue These are often temporary and tend to improve as your body adjusts

GLP-1 receptor agonists downregulate aberrant GnT-III expression in alzheimers disease models through the Akt/GSK-3beta/beta-catenin signaling